Interferon alfa-n3 Completed Phase 2 Trials for Melanoma Stage Iv / Recurrent Melanoma Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00026143Interleukin-12 and Interferon Alfa in Treating Patients With Metastatic Malignant Melanoma